April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Cydar Medical, a developer of cloud-based artificial intelligence solutions for endovascular surgery, announced an expanded relea ...

Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...

Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its ...

Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, ...

Concept Medical Inc. announced preliminary 3-year follow-up data from the SIRONA randomized trial comparing the company’s M ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Reva Medical, LLC announced primary endpoint results from the pivotal MOTIV BTK randomized clinical trial evaluating the safety a ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

The location of the devitalized tissue also affects amputation risk, healing potential, and quality of life. Dosluoglu et al confirmed we anecdotally know that necrotic heel ulcerations do poorly, and ...